Quick Answer
There is no single best GLP-1 for every woman over 40. The right fit usually comes down to budget, side-effect tolerance, and whether you want strongest efficacy or simplest access.
Semaglutide (Wegovy) = most familiar mainstream path. Tirzepatide (Zepbound) = strongest weight-loss upside. Compounded programs = lower-cost entry through telehealth.
Why Women Over 40 Ask This Differently
Perimenopause/menopause shifts, slower recovery, insulin resistance, appetite dysregulation, rising cholesterol, old strategies stopped working.
Comparison Table
| Option | Best for | Main tradeoff |
|---|---|---|
| Wegovy/semaglutide | Mainstream familiarity, strong data | Expensive without coverage |
| Zepbound/tirzepatide | Strongest efficacy ceiling | Pricier, insurance-dependent |
| Compounded semaglutide | Cash-pay budget | Different regulatory category |
| Compounded tirzepatide | Stronger upside, cash-pay | More expensive than compounded sema |
| Insurance-first programs | Strong commercial insurance | Approval can be slow |
FAQ
Is tirzepatide better than semaglutide for women over 40? Often viewed as stronger, but stronger doesn’t mean better for everyone.
Are GLP-1s safe for women over 40? Depends on health history. Clinician evaluation required.
What if I’m in perimenopause? One reason many women explore GLP-1s when weight gain feels resistant to diet/exercise.
Is the cheapest option the worst? Not necessarily. Lower-cost paths involve different tradeoffs.